General
DDW Numbered Memo 2022-10
Developmental Disabilities Waiver - General
October 13, 2022
DDSD Individual Transition Plan Checklist
SW 2022-03 DDSD Individual Transition Plan Checklist
Supports Waiver - General
October 13, 2022
SW 2022-03 DDSD Individual Transition Plan Checklist
Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda - 10/06/2022
Health Emergency Management - General
October 7, 2022
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory about a recently confirmed outbreak of Ebola virus disease (EVD) in Uganda caused by Sudan virus (species Sudan ebolavirus) to summarize CDC’s recommendations for U.S. public health departments and clinicians, case identification and testing, and clinical laboratory biosafety considerations.
UNM Capacity- 09/16/2022
Health Emergency Management - General
October 4, 2022
UNM Capacity - 09/16/2022
SLD 2022 IR (Infrared) 8000 Training Schedule
Scientific Laboratory - General
September 22, 2022
SLD 2022 IR (Infrared) 8000 Training Schedule
SLD 2023 IR (Infrared) 8000 Training Schedule
Scientific Laboratory - General
September 22, 2022
SLD 2023 IR (Infrared) 8000 Training Schedule
Acute Flaccid Myelitis and Polio - 09/16/2022
Health Emergency Management - General
September 16, 2022
As of the end of August 2022, national sentinel surveillance sites for respiratory pathogens are reporting increases in pediatric hospitalizations of patients with severe respiratory illness who also tested positive for rhinovirus (RV) and/or enterovirus (EV).
RV-EV Respiratory Illness
Health Emergency Management - General
September 16, 2022
RV-EV Respiratory Illness
HAN Flu Vaccination Reccomendations
Health Emergency Management - General
September 16, 2022
Reccomendations for HAN Flu Vaccinations
CDC and FDA Authorize COVID19 Bivalent Vaccine for Boosters - 09/05/2022
Health Emergency Management - General
September 8, 2022
On August 31, 2022, the FDA authorized emergency use of new bivalent formulations of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 Vaccines for use as a single booster dose at least two months following primary or booster vaccination.
Proclamation: Suicide Prevention Month 2022
Suicide Prevention - General
September 6, 2022
Suicide Prevention Month 2022
Vaccine Purchase Act Provider Listing 2023
Immunization - General
August 31, 2022
This is a list of provider names.
Vaccine Purchase Act Cost Estimates FY23
Immunization - General
August 31, 2022
This is a list of provider cost list
Presbyterian Community Health - May 2022 Spanish CHW Training
Community Health Workers - General
August 26, 2022
Presbyterian Community Health - May 2022 Spanish CHW Training
Environmental Protection Agency Drinking Water Certificate for Chemistry & Microbiology
Scientific Laboratory - General
August 18, 2022
The United States Environmental Protection Agency region 6 certifies that the New Mexico Department of Health Scientific Laboratory Division has bet the requirements for certification of laboratories analyzing drinking water and is hereby certified to conduct analysis of drinking water samples for inorganic chemistry and radiochemistry as specified in the scope of certification.
DDSD COVID-19 Memo Directives Rescinded across all Services and Programs - August 15, 2022
COVID-19 Information for DD Providers - General
August 16, 2022
DDSD COVID-19 Memo Directives Rescinded across all Services and Programs - August 15, 2022
Monkeypox Update - 08/09/2022
Health Emergency Management - General
August 9, 2022
As of August 8, 2022, the Centers for Disease Control and Prevention (CDC) and state and local public health departments are reporting 8934 confirmed and probable cases of monkeypox in the United States across 49 states, Washington D.C., and Puerto Rico
DDW Numbered Memo 2022-9
Developmental Disabilities Waiver - General
August 4, 2022
Suspension of Supported Employment Leadership Network (SELN)reporting requirements for State Fiscal Year (FY) 2023
Mixed Caseload Communication
Developmental Disabilities Waiver - General
August 4, 2022
Mixed Caseload Communication
Paxlovid - 07/19/2022
Health Emergency Management - General
July 19, 2022
Paxlovid is a highly effective treatment against COVID-19. In clinical trials, Paxlovid was shown to have an 88% reduction in hospitalization and death.